Overview
Nations Trust Bank is a diversified Sri Lankan commercial bank serving retail, SME and corporate clients with lending, cards, trade and transaction banking, and treasury solutions. The most material recent change is a strengthened capital stack via a fully allotted Basel III Tier 2 debenture, alongside continued profitability improvement into March 2026.
Price performance
Momentum has been resilient versus the market. The share is up 30.1% over 1 year against the ASPI’s 9.3%. Shorter windows are also better-than-market: -3.8% over 3 months vs -6.5% for the ASPI and -10.8% over 6 months vs -11.3%.
Valuation
The voting line trades at 5.15x P/E, sitting around the 20th percentile inside banks/finance, and near book at 1.04x P/B (mid-sector). FY2025 ROE was 19.9%, consistent with a P/B modestly above book. The dividend yield is 3.4% (upper-third in sector terms), with a low 17.6% payout (cover 5.67x) offering room to lift distributions if earnings hold.
News and sentiment
Coverage has been unusually quiet: 2 material articles in 30 days vs a 4.7 monthly baseline (ratio 0.4). Tone is net positive over 90 days (9 positive, 2 negative across 15). The LKR 15 billion Basel III Tier 2 issue was fully allotted after a roughly 1.3x book and was rated BBB+(lka) by Fitch. A routine quarterly window for converting non-voting to voting shares remains in place, and one independent non-executive director was added to the Board.
Financials
The Mar-2026 quarter extended growth: net profit grew 12.0% year-on-year. Operating margin was 50.9% versus 51.0% a year ago, while net margin edged up to 33.1% versus 33.0%, the best March quarter in nine on this measure. For FY2025, revenue rose 17.8% and net profit 14.6%, with a 36.8% net margin and 19.9% ROE. Below-the-line charges remain material for a bank, and gross margin is not meaningful for this business model.
Risks
New subordinated Tier 2 coupons up to 13.95% add to funding costs until repricing flows through. Share conversions from the non-voting line can dilute per-share metrics across time. The stock’s beta to the ASPI is 1.58, implying sharp index-divergent moves are possible. Sector AML/compliance scrutiny is elevated per recent regulatory commentary.
Outlook
Next catalyst is the June 2026 quarter result, due by 2026-10-28. As at 6 Aug 2026, market rates have been edging down in the backdrop, which is consistent with easing funding costs later in 2026; the immediate question is whether NTB sustains year-on-year profit growth after the Tier 2 issuance.